|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 379.98 USD | +2.77% |
|
+3.04% | +15.11% |
| 05-08 | Molina bets on medical cost control for fivefold profit jump by 2029 | RE |
| 05-06 | CVS Health raises 2026 forecast after improving medical cost controls | RE |
Evolution of the Average Target: UnitedHealth Group Inc.
Evolution of the Target Price: UnitedHealth Group Inc.
Changes in Analyst Recommendations: UnitedHealth Group Inc.
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +1.92% | |||||
| +2.88% | |||||
| +18.2% | |||||
| -11.37% | |||||
| -1.82% | |||||
| -2.82% | |||||
| +40.29% | |||||
| +17.66% | |||||
| -9.72% | |||||
| +45.97% | |||||
| Average | +10.12% | |||||
| Weighted average by Cap. | +3.46% |
Analysts' Consensus
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| JPMorgan Chase | |
| TD Cowen | |
| Raymond James | |
| Bernstein | |
| Piper Sandler | |
| RBC Capital Markets | |
| Truist Securities | |
| Oppenheimer | |
| Argus | |
| Deutsche Bank Securities | |
| Morgan Stanley | |
| Evercore ISI | |
| Leerink Partners | |
| Baird | |
| Barclays | |
| Wells Fargo Securities | |
| Goldman Sachs | |
| Jefferies & Co. | |
| HSBC | |
| Wolfe Research | |
| Mizuho Securities | |
| UBS | |
| BofA Securities | |
| KeyBanc Capital Markets | |
| Nephron Research | |
| Stephens Inc. | |
| Cantor Fitzgerald | |
| SVB Securities LLC | |
| Morningstar | |
| Loop Capital | |
| Credit Suisse | |
| BMO Capital | |
| SVB Leerink | |
| RBC | Ben Hendrix |
| Edward Jones | |
| Morgan Joseph | |
| Citigroup | |
| Seaport Global Securities |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- UNH Stock
- Consensus UnitedHealth Group Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition